1. Home
  2. PPSI vs PLUR Comparison

PPSI vs PLUR Comparison

Compare PPSI & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$3.27

Market Cap

36.3M

Sector

Industrials

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.37

Market Cap

33.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
PLUR
Founded
2008
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
33.9M
IPO Year
2008
2001

Fundamental Metrics

Financial Performance
Metric
PPSI
PLUR
Price
$3.27
$3.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
128.9K
4.7K
Earning Date
04-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.78
EPS
N/A
N/A
Revenue
$27,627,000.00
$1,336,000.00
Revenue This Year
$2.71
$97.38
Revenue Next Year
$22.42
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
20.75
309.82
52 Week Low
$2.31
$2.82
52 Week High
$5.70
$6.10

Technical Indicators

Market Signals
Indicator
PPSI
PLUR
Relative Strength Index (RSI) 58.44 49.22
Support Level $3.11 $3.22
Resistance Level $3.48 $3.42
Average True Range (ATR) 0.23 0.14
MACD 0.09 -0.00
Stochastic Oscillator 87.61 25.37

Price Performance

Historical Comparison
PPSI
PLUR

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: